Description

This book is the first systematic, detailed treatment of the approaches to ethical issues taken by biotech and pharmaceutical companies. The application of genetic/genomic technologies raises a whole spectrum of ethical questions affecting global health that must be addressed. Topics covered in this comprehensive survey include considerations for bioprospecting in transgenics, genomics, drug discovery, and nutrigenomics, as well as how to improve stakeholder relations, design ethical clinical trials, avoid conflicts of interest, and establish ethics advisory boards. The expert authors represent multiple disciplines including law, medicine, bioinformatics, pharmaceutics, business, and ethics.

Readership

Advanced undergraduate and graduate students in courses focusing on biotechnology in business, law medicine, biology and public health; Managers and employees in biotech and pharmaceutical companies as well as venture capitalists and financial analysts

Details

No. of pages:
384
Language:
English
Copyright:
© 2005
Published:
Imprint:
Academic Press
Print ISBN:
9780123693709
Electronic ISBN:
9780080492513

About the authors

David Finegold

Affiliations and Expertise

Strategy & Organization Studies, Keck Graduate Institute for the Applied Life Sciences

Cecile Bensimon

Affiliations and Expertise

University of Toronto Joint Centre for Bioethics

Abdallah Daar

Affiliations and Expertise

University of Toronto Joint Centre for Bioethics

Margaret Eaton

Affiliations and Expertise

Stanford University Center for Biomedical Ethics

Beatrice Godard

Affiliations and Expertise

Faculté de médecine, Université de Montréal

Bartha Knoppers

Affiliations and Expertise

Faculté de droit, Université de Montréal

Jocelyn Mackie

Affiliations and Expertise

University of Toronto Joint Centre for Bioethics

Peter Singer

Affiliations and Expertise

University of Toronto Joint Centre for Bioethics

Reviews

"Biotechnology and pharmaceutical companies are often driven by profit goals, but the case studies in Bioindustry Ethics show that this is increasingly not at the expense of ethical integrity. ...lend[s] important insights to other executives and professionals who might be developing their own practices and policies." - GENOMICS & PROTEOMICS (August 2005)